ABCB1 and cancer: Our mechanism study also indicated that midostaurin could increase the accumulation of certain substrate-drugs (doxorubicin and [3H]-paclitaxel) in ABCB1-overexpression cancer cells by targeting the function of ABCB1 transporter.